Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensitivity to GCs are either imprecise or based on inhibition by GCs of lymphocyte proliferation following stimulation with phytohemagglutinin or other mitogens, which may influence the GC signal transduction pathway. Using the human lymphoblastoid cell line IM-9 as a model system, we studied whether the GC-induced increase of the mRNA encoding the 51-kDa FK506-binding protein (FKBP51) could be used for the development of a novel assay, ultimately to be used in native human peripheral blood mononuclear cells (PBMCs). GC addition to IM-9 cells resulted in a dose-dependent increase of FKBP51 mRNA levels within 2 h, followed by a further increase until 24 h. Northern blot analysis and real-time PCR yielded similar results. Coincubation of GCs with the GC receptor antagonist ORG 34116 or the protein synthesis inhibitor cycloheximide suggested a direct, GC receptor-mediated up-regulation of FKBP51 gene transcription. Expected differences in potency among different GCs could be readily demonstrated in this system. Extending our observations in IM-9 lymphoblasts to normal PBMCs, we found a dose-dependent increase of FKBP51 mRNA on ex vivo incubation of native human PBMCs with GCs, with a sensitivity of about 10(-9) M for dexamethasone. Moreover, dexamethasone ingestion increased FKBP51 mRNA in PBMCs in vivo, extending the use of this assay to the measurement of GC bioavailability. Finally, using this method we were able to demonstrate partial GC-insensitivity in a 6-month-old infant suffering from congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. We conclude that the induction of FKBP51 mRNA by GCs may be a suitable marker to assess individual GC sensitivity, the in vitro measurement of GC potency, and the in vivo determination of GC bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of FKBP5 is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 induction by GR activation has been proposed as a molecular indicator of GR sensitivity (Ja ¨a ¨skela ¨inen et al, 2011;Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
Citations
Cites
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892 · cited 1×
“This number was used to relate the initial quantity of cDNA of interest in each sample to one another (21).”
MethodTranscriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., & Logsdon, C. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69104-5 · Cited by 322 · cited 1×
“On the other hand, it has been reported that GCs induce downregulation of GC receptor mRNA itself in IM-9 cells (41).”
BackgroundThe human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319 · cited 1×
“Primers used were 5 -AAAAGGCCAAGGAGCACAAC-3 and 5 -TTGAGGAGGGGCCGAGTTC-3 for the FKBP51 PCR (TIB-Molbiol, Berlin, Germany) and 5 -CCAGCAGAGAATGGAAAGTC-3 and 5 -GATGCTGCTTACATGTCTCG-3 for the 2-microglobulin ( 2m) PCR (20).”
MethodHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 1×
“Partial insensitivity to glucocorticoids can be caused by several mechanisms and has been described in many other patients (42).”
BackgroundNair, S. C., Rimerman, R. A., Toran, E. J., Chen, S., Prapapanich, V., Butts, R. N., & Smith, D. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.594 · Cited by 196 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
Background
Cited by
Machines and Mindlessness: Social Responses to Computers
Nass, C., & Moon, Y. (2000) · Journal of Social Issues · doi:10.1111/0022-4537.00153 · Cited by 4,022
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
“FKBP5 expression is induced by glucocorticoids as part of an intracellular ultrashort negative feedback loop for GR activity.(53) Overexpression of human FKBP5 in vitro reduces hormone binding affinity(54) and nuclear translocation of GR.”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
“Another interesting feature of FKBP5 is that its expression is induced by steroids, including glucocorticoids as part of an intracellular ultra-short negative feedback loop for GR activity (Vermeer et al., 2003).”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“…is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003), such that increased expression of FKBP5 following GR activation leads to the subsequent reduction in GR sensitivity (Binder,…”
BackgroundGene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
“However, FKBP5 induction can vary across individuals and has been proposed as a marker of GR sensitivity (Kelly et al, 2012; Menke et al, 2012; Vermeer et al, 2003).”
BackgroundTafet, G. E., & Nemeroff, C. B. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15030053 · Cited by 393
Risk and resilience: genetic and environmental influences on development of the stress response
Gillespie, C. F., Phifer, J., Bradley, B., & Ressler, K. J. (2009) · Depression and Anxiety · doi:10.1002/da.20605 · Cited by 351
“3) is a co-chaperone component of the GR heterocomplex([53,54]) that plays a key role in the regulation of GR sensitivity and hence the expression of glucocorticoid-responsive genes by virtue of its participation in an ultra-short, intracellular negative feedback loop regulating GR activity.([55]) Several lines of dat…”
BackgroundGenome-wide Expression Analysis of Mouse Liver Reveals CLOCK-regulated Circadian Output Genes
Oishi, K., Miyazaki, K., Kadota, K., Kikuno, R., Nagase, T., Atsumi, G.-I., Ohkura, N., Azama, T., Mesaki, M., Yukimasa, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304564200 · Cited by 341
Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder
Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Farrer, L. A., & Gelernter, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.37 · Cited by 327
“In addition, FKBP5 and the glucocorticoid receptor form a negative feedback loop, with FKBP5 gene expression induced by glucocorticoid (Binder et al , 2004; Vermeer et al , 2003).”
Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C., & Yamamoto, K. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407008101 · Cited by 320
Hypothalamic–pituitary–adrenal axis and stress
(2020) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64123-6.00004-7 · Cited by 279
Gene–environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism
Zannas, A. S., & Binder, E. B. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12104 · Cited by 268
“In summary, the rapid induction of FKBP5 in response to GR activation and the inhibitory effect of FKBP5 on GR activity create an intracellular, ultra-short, negative feedback loop that regulates GR sensitivity (Vermeer et al. 2003).”
BackgroundZimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E. B., Uhr, M., Lieb, R., Moffitt, T. E., Caspi, A., Holsboer, F., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111577 · Cited by 262
“In addition, glucocorticoids induce FKBP5 expression as part of an intracellular ultrashort negative feedback loop for glucocorticoid receptor activity (8).”
BackgroundHartmann, K., Koenen, M., Schauer, S., Wittig-Blaich, S., Ahmad, M., Baschant, U., & Tuckermann, J. P. (2016) · Physiological Reviews · doi:10.1152/physrev.00011.2015 · Cited by 247
Genomic and epigenomic mechanisms of glucocorticoids in the brain
Gray, J. D., Kogan, J. F., Marrocco, J., & McEwen, B. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.97 · Cited by 242
Appel, K., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Stender, J., Barnow, S., John, U., Teumer, A., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.81 · Cited by 234
“Functionally, cortisol induces the FKBP5 expression by activation of glucocorticoid-response-elements (Vermeer et al., 2003).”
BackgroundGene × environment vulnerability factors for PTSD: The HPA-axis
Mehta, D., & Binder, E. B. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.009 · Cited by 213
Hartmann, J., Wagner, K. V., Liebl, C., Scharf, S. H., Wang, X.-D., Wolf, M., Hausch, F., Rein, T., Schmidt, U., Touma, C., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.041 · Cited by 224
“Moreover, the expression of FKBP5 is stimulated by steroids, such as GCs, as part of an intracellular ultra-short negative feedback loop for GR activity (Hubler and Scammell, 2004; Vermeer et al., 2003).”
BackgroundGene × Environment Interactions: From Molecular Mechanisms to Behavior
Halldorsdottir, T., & Binder, E. B. (2017) · Annual Review of Psychology · doi:10.1146/annurev-psych-010416-044053 · Cited by 188
Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain
Scharf, S. H., Liebl, C., Binder, E. B., Schmidt, M. V., & Müller, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016883 · Cited by 202
“The strongest increase in mRNA in the hippocampus is 187% (see Table 3) and we do not think this is already saturation, as in the PVN and the CeA increases up to 661% are possible and data from cell lines (lymphoblast IM9) show increases of up to 1000% [12].”
BackgroundMolecular links between endocrine, nervous and immune system during chronic stress
Zefferino, R., Di Gioia, S., & Conese, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1960 · Cited by 204
“FKBP expression itself is induced by GCs as part of an intracellular ultra-short negative feedback loop for GR activity (Vermeer et al., 2003).”
BackgroundIntronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids
Hubler, T. R., & Scammell, J. G. (2004) · Cell Stress & Chaperones · doi:10.1379/csc-32r.1 · Cited by 201
“On the other hand, FKBP51 is increased by glucocorticoids (Baughman et al 1997; Reynolds et al 1998; Wan and Nordeen 2002; Vermeer et al 2003), progestins (Kester et al 1997; Richer et al 2002; Wan and Nordeen 2002; Hubler et al 2003), and androgens (Amler et al 2000; Mousses et al 2001; Zhu et al…”
BackgroundArgentieri, M. A., Nagarajan, S., Seddighzadeh, B., Baccarelli, A. A., & Shields, A. E. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.044 · Cited by 188
“Expression of FKBP5mRNA is induced by glucocorticoids, however, leading to an ultra-short negative feedback loop wherein greater circulating levels of glucocorticoids induce greater FKBP5 protein expression, thus regulating GR signaling within an appropriate range (Vermeer et al., 2003).”
BackgroundMachado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0610 · Cited by 195
Menke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
BackgroundSteroid up-regulation of FKBP51 and its role in hormone signaling
Jääskeläinen, T., Makkonen, H., & Palvimo, J. J. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.006 · Cited by 167
Post‐traumatic stress disorder and beyond: an overview of rodent stress models
Schöner, J., Heinz, A., Endres, M., Gertz, K., & Kronenberg, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13161 · Cited by 150
Hypothalamic-Pituitary-Adrenal Axis Dysfunction and Illness Progression in Bipolar Disorder
Fries, G. R., Vasconcelos-Moreno, M. P., Gubert, C., Santos, B. T. M. Q. D., Sartori, J., Eisele, B., Ferrari, P., Fijtman, A., Ruegg, J., Gassen, N. C., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu043 · Cited by 147
“Interestingly, glucocorticoids can induce the expression of FKBP51 as part of an intracellular ultra-short negative feedback loop for GR activity (Vermeer et al., 2003).”
BackgroundTetratricopeptide repeat cochaperones in steroid receptor complexes
Smith, D. F. (2004) · Cell Stress and Chaperones · doi:10.1379/csc-31.1 · Cited by 166
“One group suggested recently that hormone-induced FKBP51 expression could be a useful clinical marker for GR sensitivity and bioavailability in patients (Vermeer et al 2003).”
BackgroundRohleder, N., Wolf, J. M., & Wolf, O. T. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.003 · Cited by 150
“Lastly, GR sensitivity is additionally regulated by GCs inducing the expression of FKBP5, thereby constituting an intracellular ultra-short negative feedback loop (Hubler and Scammell, 2004; Vermeer et al., 2003).”
BackgroundIdentification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
Schmidt, S., Rainer, J., Riml, S., Ploner, C., Jesacher, S., Achmüller, C., Presul, E., Skvortsov, S., Crazzolara, R., Fiegl, M., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2853 · Cited by 149
Roy, B., Shelton, R. C., & Dwivedi, Y. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.005 · Cited by 139
“Several lines of evidence indicate strong functional link between active GR and induced transcription of FKBP5 gene, which may act as feedback loop to regulate GR sensitivity (Vermeer et al., 2003).”
Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function
Balsevich, G., Häusl, A. S., Meyer, C. W., Karamihalev, S., Feng, X., Pöhlmann, M. L., Dournes, C., Uribe-Marino, A., Santarelli, S., Labermaier, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01783-y · Cited by 134
Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease
Salminen, A., Ojala, J. O., Kaarniranta, K., Hiltunen, M., & Soininen, H. S. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.006 · Cited by 143
Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions
Paakinaho, V., Makkonen, H., Jääskeläinen, T., & Palvimo, J. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0443 · Cited by 122
Hähle, A., Merz, S., Meyners, C., & Hausch, F. (2019) · Biomolecules · doi:10.3390/biom9010035 · Cited by 119
Hartmann, J., Bajaj, T., Klengel, C., Chatzinakos, C., Ebert, T., Dedic, N., McCullough, K. M., Lardenoije, R., Joëls, M., Meijer, O. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109185 · Cited by 119
“Notably, the expression of Fkbp5 is stimulated by glucocorticoids as part of an intracellular ultra-short negative feedback loop for GR activity (Hubler and Scammell, 2004; Vermeer et al., 2003).”
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice
Lee, R. S., Tamashiro, K. L. K., Yang, X., Purcell, R. H., Huo, Y., Rongione, M., Potash, J. B., & Wand, G. S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2307-3 · Cited by 108
“In addition, we compared the methylation of Fkbp5 to expression, for their ability to predict cortisol burden, since some studies have suggested using Fkbp5 expression as a glucocorticoid exposure biomarker (Vermeer et al. 2003).”
BackgroundResultAnnett, S., Moore, G., & Robson, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107623 · Cited by 112
Frijters, R., Fleuren, W., Toonen, E. J., Tuckermann, J. P., Reichardt, H. M., van der Maaden, H., van Elsas, A., van Lierop, M.-J., Dokter, W., de Vlieg, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-359 · Cited by 103
“The mechanism of dimer-dependent transactivation by the GR has been studied in detail for a limited number of GR target genes, including Fkbp5 (FK506 binding protein 5), Tat, Pck1 and Dusp1 (Dual specificity phosphatase 1) [23-26], and tethering-facilitated transrepression of Mmp1/Mmp13 (Matrix metallopeptidase 1/13),…”
BackgroundPolman, J. A. E., Hunter, R. G., Speksnijder, N., van den Oever, J. M. E., Korobko, O. B., McEwen, B. S., de Kloet, E. R., & Datson, N. A. (2012) · Endocrinology · doi:10.1210/en.2012-1255 · Cited by 102
Pharmacogenomics and antidepressant drugs
Binder, E. B., & Holsboer, F. (2006) · Annals of Medicine · doi:10.1080/07853890600551045 · Cited by 100
“We have observed a much steeper correlation between FKBP5 mRNA expression in peripheral lymphocytes and serum cortisol levels in individuals carrying the genotypes associated with fast response to antidepressant than the two other genotypes, indicating an altered GR/FKBP5 feedback mechanism associated with these genot…”
BackgroundPereira, M. J., Palming, J., Svensson, M. K. E., Rizell, M., Dalenbäck, J., Hammar, M., Fall, T., Sidibeh, C. O., Svensson, P., & Eriksson, J. W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.015 · Cited by 112
“[30] Vermeer H, Hendriks-Stegeman BI, van der Burg B, et al.”
BackgroundMamdani, F., Rollins, B., Morgan, L., Myers, R. M., Barchas, J. D., Schatzberg, A. F., Watson, S. J., Akil, H., Potkin, S. G., Bunney, W. E., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.134 · Cited by 90
Elbau, I., Cruceanu, C., & Binder, E. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.025 · Cited by 101
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers
Makkonen, H., Kauhanen, M., Paakinaho, V., Jääskeläinen, T., & Palvimo, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp352 · Cited by 97
“FKBP51 expression is also upregulated by glucocorticoids and progestins in lymphocytes and breast cancer cells, respectively (39,40).”
BackgroundGenomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells
Tissing, W. J. E., den Boer, M. L., Meijerink, J. P. P., Menezes, R. X., Swagemakers, S., van der Spek, P. J., Sallan, S. E., Armstrong, S. A., & Pieters, R. (2007) · Blood · doi:10.1182/blood-2006-11-056366 · Cited by 94
Kohrt, B. A., Worthman, C. M., Ressler, K. J., Mercer, K. B., Upadhaya, N., Koirala, S., Nepal, M. K., Sharma, V. D., & Binder, E. B. (2015) · International Review of Psychiatry · doi:10.3109/09540261.2015.1020052 · Cited by 89
FKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92
“High levels of FKBP51 correlate with resistance to GC therapies for asthma [49] and chronic obstructive pulmonary disease [50], and diagnostic assays are being developed using FKBP51 as markers of GC sensitivity [51].”
BackgroundFluorescent Probes to Characterise FK506‐Binding Proteins
Kozany, C., März, A., Kress, C., & Hausch, F. (2009) · ChemBioChem · doi:10.1002/cbic.200800806 · Cited by 91
Jiang, W., Cazacu, S., Xiang, C., Zenklusen, J. C., Fine, H. A., Berens, M., Armstrong, B., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.07929 · Cited by 88
Wu, T.-C., Chen, H.-T., Chang, H.-Y., Yang, C., Hsiao, M., Cheng, M., & Chen, J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.011 · Cited by 96
“When a subject is exposed to a stressor, CRF (corticotrophin-releasing factor) from the paraventricular nucleus of the hypothalamus stimulates the release of corticotrophin (ACTH) from the anterior pituitary, which in turn evokes glucocorticord (cortisol in human or corticosterone in rodents) secretion from the adrena…”
BackgroundGenetics of glucocorticoid regulation and posttraumatic stress disorder -what do we know?
Castro-Vale, I., van Rossum, E. F. C., Machado, J. C., Mota-Cardoso, R., & Carvalho, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.005 · Cited by 85
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84
Fabbri, C., Hosak, L., Mössner, R., Giegling, I., Mandelli, L., Bellivier, F., Claes, S., Collier, D. A., Corrales, A., Delisi, L. E., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1208843 · Cited by 81
“Further supporting this notion are studies showing that increased expression of the FKBP5 gene confers elevated GR resistance (Binder, 2009) and that glucocorticoids induce FKBP5 expression (Vermeer et al. 2003).”
BackgroundReview: HPA‐axis activity in alcoholism: examples for a gene–environment interaction
Clarke, T., Treutlein, J., Zimmermann, U. S., Kiefer, F., Skowronek, M. H., Rietschel, M., Mann, K., & Schumann, G. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00084.x · Cited by 80
Klinger-König, J., Hertel, J., Van der Auwera, S., Frenzel, S., Pfeiffer, L., Waldenberger, M., Golchert, J., Teumer, A., Nauck, M., Homuth, G., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0319-6 · Cited by 78
Mamdani, F., Rollins, B., Morgan, L., Myers, R. M., Barchas, J. D., Schatzberg, A. F., Watson, S. J., Akil, H., Potkin, S. G., Bunney, W. E., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.164 · Cited by 76
Glucocorticoid-regulated genes in eosinophilic esophagitis: A role for FKBP51
Caldwell, J. M., Blanchard, C., Collins, M. H., Putnam, P. E., Kaul, A., Aceves, S. S., Bouska, C. A., & Rothenberg, M. E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.038 · Cited by 81
Galigniana, N. M., Ballmer, L. T., Toneatto, J., Erlejman, A. G., Lagadari, M., & Galigniana, M. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07775.x · Cited by 77
“Importantly, glucocorticoids self-regulate their own effects by inducing the expression of FKBP51 (Vermeer et al. 2003)(Fig.”
BackgroundInterplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51
Balsevich, G., Uribe, A., Wagner, K. V., Hartmann, J., Santarelli, S., Labermaier, C., & Schmidt, M. V. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0129 · Cited by 71
“The CSDS paradigm lasted for 21 days and was conducted as described previously (Wagner et al. 2011, 2012).”
Xu, J., Wang, R., Liu, Y., Liu, D., Jiang, H., & Pan, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.010 · Cited by 79
“In addition, GC can induce the expression of FKBP5, completing an intracellular ultra-short negative feedback loop to regulate GR activity (Hubler and Scammell, 2004; Vermeer et al., 2003).”
BackgroundHohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
Kitraki, E., Nalvarte, I., Alavian-Ghavanini, A., & Rüegg, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.028 · Cited by 72
Allele-specific DNA methylation level of FKBP5 is associated with post-traumatic stress disorder
Kang, J. I., Kim, T. Y., Choi, J. H., So, H. S., & Kim, S. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.226 · Cited by 66
Focus on FKBP51: A molecular link between stress and metabolic disorders
Häusl, A. S., Balsevich, G., Gassen, N. C., & Schmidt, M. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.003 · Cited by 81
“Equally important, however, is that FKBP51 expression in turn is induced by GR activation itself, representing an ultra-short, negative feedback loop regulating GR sensitivity [51].”
BackgroundThe Neurobiology of Bipolar Disorder: An Integrated Approach
Muneer, A. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.1.18 · Cited by 68
“Intriguingly, this hormone acting via an intracellular ultra-short negative feedback loop for GR activity can stimulate the expression of FKBP51.(18) There is a known familial contribution to the neurobiology of BD, and it is probable that most of the cortisol-GR-related mechanisms alluded to above are a sign of the p…”
BackgroundMechanisms and clinical consequences of critical illness associated adrenal insufficiency
Marik, P. E. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32818a6d74 · Cited by 76
Dackis, M. N., Rogosch, F. A., Oshri, A., & Cicchetti, D. (2012) · Development and Psychopathology · doi:10.1017/s0954579412000673 · Cited by 71
Wilker, S., Pfeiffer, A., Kolassa, S., Elbert, T., Lingenfelder, B., Ovuga, E., Papassotiropoulos, A., de Quervain, D., & Kolassa, I.-T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.49 · Cited by 66
Understanding epigenetic architecture of suicide neurobiology: A critical perspective
Roy, B., & Dwivedi, Y. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.031 · Cited by 69
“Most interestingly, the data from this study might be indicating the functional involvement of an ultrashort negative feedback loop that orchestrates the GR repression by FKBP5 and vice versa (Vermeer et al., 2003; Zannas et al., 2016).”
BackgroundInterpretation of ANOVA models for microarray data using PCA
de Haan, J. R., Wehrens, R., Bauerschmidt, S., Piek, E., van Schaik, R. C., & Buydens, L. M. C. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl572 · Cited by 70
“Furthermore FKBP5 is induced by dexamethasone (Vermeer et al., 2003).”
Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Hunt, H., Donaldson, K., Strem, M., Zann, V., Leung, P., Sweet, S., Connor, A., Combs, D., & Belanoff, J. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.389 · Cited by 65
Grabe, H. J., Wittfeld, K., Van der Auwera, S., Janowitz, D., Hegenscheid, K., Habes, M., Homuth, G., Barnow, S., John, U., Nauck, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23123 · Cited by 67
“Functionally, cortisol induces FKBP5 gene expression by activation of glucocorticoid-response-elements [Vermeer et al., 2003].”
BackgroundBrooks, A. K., Lawson, M. A., Smith, R. A. J., Janda, T. M., Kelley, K. W., & McCusker, R. H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0563-1 · Cited by 70
“FKBP51 acts as negative regulator by preventing translocation of corticosteroid receptor complexes (CR:R) to the nucleus whereas FKBP52 serves as a positive regulator by binding to and translocating the CR:R complex to the nucleus to self-regulate their activity primarily via the regulation of FKBP51 expression [50].”
BackgroundLinnstaedt, S. D., Riker, K. D., Rueckeis, C. A., Kutchko, K. M., Lackey, L., McCarthy, K. R., Tsai, Y.-H., Parker, J. S., Kurz, M. C., Hendry, P. L., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-17.2018 · Cited by 66
“Allele-dependent relationship between circulating cortisol levels and FKBP5 mRNA expression Cortisol induces the expression of FKBP5 (Vermeer et al., 2003), and FKBP5 reduces the nuclear transport of cortisol required for negative feedback inhibition, resulting in relatively increased cortisol levels (Tatro et al.”
BackgroundDose- and time-dependent glucocorticoid receptor signaling in podocytes
Guess, A. J., Agrawal, S., Wei, C., Ransom, R. F., Benndorf, R., & Smoyer, W. E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00161.2010 · Cited by 66
Mechanisms of brain glucocorticoid resistance in stress-induced psychopathologies
Merkulov, V. M., Merkulova, T. I., & Bondar, N. P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030142 · Cited by 65
“In blood cells and bronchial epithelium, GCs increase the amounts of both FKBP5 mRNA and the corresponding protein product [72-75].”
BackgroundXu, J., Wang, R., Liu, Y., Wang, W., Liu, D., Jiang, H., & Pan, F. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.008 · Cited by 61
Wagner, K. V., Marinescu, D., Hartmann, J., Wang, X., Labermaier, C., Scharf, S. H., Liebl, C., Uhr, M., Holsboer, F., Müller, M. B., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.150 · Cited by 66
“…this study, Menke et al (2012) could show that a dexamethasone challenge is rapidly increasing FKBP51 mRNA levels in peripheral blood, suggesting a prominent role of FKBP51 in the intracellular short feedback loop to immediately reduce GR sensitivity in response to a stressor (Vermeer et al, 2003).”
BackgroundHuang, M., Schwandt, M. L., Chester, J. A., Kirchhoff, A. M., Kao, C., Liang, T., Tapocik, J. D., Ramchandani, V. A., George, D. T., Hodgkinson, C. A., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.55 · Cited by 64
“For example, in vitro exposure of cells to glucocorticoids induces an increase in FKBP5 mRNA, with genotypes composed of rs1360780 and rs3800373 minor alleles being the highest expressing variants (Vermeer et al, 2003).”
BackgroundBouligand, J., Delemer, B., Hecart, A.-C., Meduri, G., Viengchareun, S., Amazit, L., Trabado, S., Fève, B., Guiochon-Mantel, A., Young, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013563 · Cited by 60
“Finally, owing to this decrease in the functional GR concentration in the proband’s fibroblasts, significantly below-normal induction of FKBP5, a glucocorticoid-induced target gene [16], was observed after DEX exposure (Fig.”
BackgroundFKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
Ising, M., Maccarrone, G., Brückl, T., Scheuer, S., Hennings, J., Holsboer, F., Turck, C. W., Uhr, M., & Lucae, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030485 · Cited by 60
“This is in agreement with previous findings, suggesting that peripheral FKBP5 RNA expression is induced by elevated glucocorticoid levels in patients with affective and anxiety disorders [20], which could also be confirmed in a human lymphoblastoid cell line model [29].”
Corticotropin releasing factor receptor antagonists for major depressive disorder
Paez-Pereda, M., Hausch, F., & Holsboer, F. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.565330 · Cited by 58
“There is also a strong correlation between FKBP5 mRNA expression in peripheral lymphocytes and serum cortisol levels in individuals carrying the genotypes associated with fast response to antidepressants than the other genotypes, indicating an altered GR/FKBP5 feedback mechanism associated with these genotypes [10,122…”
BackgroundMoore, N. L. T., Buchanan, G., Harris, J. M., Selth, L. A., Bianco‐Miotto, T., Hanson, A. R., Birrell, S. N., Butler, L. M., Hickey, T. E., & Tilley, W. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0065 · Cited by 61
“…mRNA levels for FKBP5, a well-characterized androgen-, progestin-, www.endocrinology-journals.org and glucocorticoid-regulated gene (Hubler et al. 2003, Vermeer et al. 2003, Magee et al. 2006), were significantly increased by DHT, MPA, and dexamethasone but not by any other ligands tested (Fig.”
BackgroundMacedo, J. A., Hesse, J., Turner, J. D., Meyer, J., Hellhammer, D. H., & Muller, C. P. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.012 · Cited by 62
“Glucocorticoid-induced leucine zipper (GILZ; TSC22D3) and the FK506 binding protein 5 (FKBP5) are two prominent GC-induced genes (Cannarile et al., 2001; Vermeer et al., 2003; U et al., 2004).”
BackgroundFKBP51 Controls Cellular Adipogenesis through p38 Kinase-Mediated Phosphorylation of GRα and PPARγ
Stechschulte, L. A., Hinds, T. D., Khuder, S. S., Shou, W., Najjar, S. M., & Sánchez, E. R. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1022 · Cited by 62
Minelli, A., Maffioletti, E., Cloninger, C. R., Magri, C., Sartori, R., Bortolomasi, M., Congiu, C., Bignotti, S., Segala, M., Giacopuzzi, M., et al. (2013) · Depression and Anxiety · doi:10.1002/da.22158 · Cited by 52
“To explain the possible role played by FKBP5 genetic variants in anxiety, we should consider the modulatory effect of FKBP5 on GR sensitivity and nuclear translocation,[8] together with the regulation exerted by glucocorticoids on its expression as part of an intracellular negative feedback pathway regulating GR activ…”
BackgroundSmit, P., Russcher, H., de Jong, F. H., Brinkmann, A. O., Lamberts, S. W. J., & Koper, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2298 · Cited by 54
Wieck, A., Grassi-Oliveira, R., Hartmann do Prado, C., Teixeira, A. L., & Bauer, M. E. (2014) · Neuroimmunomodulation · doi:10.1159/000356552 · Cited by 51
Holmstrom, S. R., Chupreta, S., So, A. Y.-L., & Iñiguez-Lluhí, J. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0581 · Cited by 53
Ellsworth, K. A., Eckloff, B. W., Li, L., Moon, I., Fridley, B. L., Jenkins, G. D., Carlson, E., Brisbin, A., Abo, R., Bamlet, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070216 · Cited by 48
“This relationship might be due to the fact that FKBP5 regulates GR activity [21,30,31] which influences GR function as a transcription factor that can regulate both FKBP5 gene expression and the expression of GR itself [26,27,28].”
BackgroundHunsberger, J. G., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.103 · Cited by 51
“1) of GR activity (Vermeer et al., 2003).”
Horie‐Inoue, K., Takayama, K., Bono, H. U., Ouchi, Y., Okazaki, Y., & Inoue, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.188 · Cited by 52
Metadata
- Authors
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 277-284
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087836842
- Cited by
- 285
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoids, FKBP51, FKBP, glucocorticoid receptor, gene transcription, lymphocytes, peripheral blood mononuclear cells, glucocorticoid sensitivity, glucocorticoid potency, dexamethasone, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cycloheximide
- MeSH terms
- Tacrolimus Binding Protein 5, Biological Availability, Computer Systems, Dexamethasone, Drug Resistance, Female, Glucocorticoids, Humans, Infant, Lymphocytes, Receptors, Glucocorticoid, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Blotting, Northern, Biomarkers, Polymerase Chain Reaction, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.